ABT
Ticker
Abbott Laboratories
Company
Devices
Industry
Healthcare
Sector
+
2009
+
2010
+
2011
+
2012
+
2013
+
2014
+
2015
+
2016
+
2017
+
2018
+
2019
+
2020
+
2021
+
2022
+
2023
+
2024
+
2025
TTM
Revenue Growth YoY
14.3%10.5%2.6%-45.2%-7.3%0.8%2.2%31.3%11.6%4.3%8.5%24.5%1.3%-8.1%4.6% 6.4%
Revenue Growth QoQ
Gross Margin
57.1%58.3%60.0%62.1%54.0%54.5%57.1%56.7%55.0%58.4%58.5%56.6%57.0%56.1%55.2%55.4% 55.9%
EBITDA Margin
27.1%24.8%22.6%27.3%19.9%20.5%21.3%21.8%20.6%22.8%23.7%25.1%27.8%26.6%24.2%23.9% 24.7%
Operating Margin
20.3%17.3%14.8%20.3%12.0%12.8%14.1%15.3%6.3%11.9%14.2%15.5%19.6%19.2%16.2%16.3% 17.6%
Profit Margin
18.7%13.2%12.2%15.0%11.8%11.3%21.7%6.7%1.7%7.7%11.6%13.0%16.4%15.9%14.3%31.9% 31.9%
FCF / EBITDA
74.3%88.6%85.0%69.2%50.1%62.6%42.8%45.9%78.4%70.5%59.6%65.9%72.3%67.1%52.0%63.2% 63.8%